China Health Technology Group Holding Co (HKSE:01069) Change In Receivables : HK$0.00 Mil (TTM As of Jun. 2024)

View and export this data going back to 2009. Start your Free Trial

What is China Health Technology Group Holding Co Change In Receivables?

China Health Technology Group Holding Co's change in receivables for the quarter that ended in Jun. 2024 was HK$0.00 Mil. It means China Health Technology Group Holding Co's Accounts Receivable stayed the same from Dec. 2023 to Jun. 2024 .

China Health Technology Group Holding Co's change in receivables for the fiscal year that ended in Jun. 2024 was HK$-8.56 Mil. It means China Health Technology Group Holding Co's Accounts Receivable increased by HK$8.56 Mil from Jun. 2023 to Jun. 2024 .

China Health Technology Group Holding Co's Accounts Receivable for the quarter that ended in Jun. 2024 was HK$18.67 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. China Health Technology Group Holding Co's Days Sales Outstanding for the six months ended in Jun. 2024 was 110.72.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. China Health Technology Group Holding Co's liquidation value for the six months ended in Jun. 2024 was HK$-159.66 Mil.

China Health Technology Group Holding Co Change In Receivables Historical Data

The historical data trend for China Health Technology Group Holding Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Health Technology Group Holding Co Change In Receivables Chart

China Health Technology Group Holding Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Jun22

Jun23

Jun24

Change In Receivables

Get a 7-Day Free Trial

-41.69

3.99

-7.00

-8.56

China Health Technology Group Holding Co Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

China Health Technology Group Holding Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.00 Mil.

China Health Technology Group Holding Co (HKSE:01069) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

China Health Technology Group Holding Co's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	18.67	/	30.774	*	91
=	110.72

2. In Ben Graham's calculation of liquidation value, China Health Technology Group Holding Co's accounts receivable are only considered to be worth 75% of book value:

China Health Technology Group Holding Co's liquidation value for the quarter that ended in Jun. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	3.477	-	177.848	+	0.75 * 18.67	+	0.5 * 1.409
=	-159.66

China Health Technology Group Holding Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of China Health Technology Group Holding Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

China Health Technology Group Holding Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Forest Products » China Health Technology Group Holding Co Ltd (HKSE:01069) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

CHBOF:USA

Address

Binhe Road South, Room 4101, Phase II Jingji Binhe Shidai Tower North, Futian District, Shenzhen, CHN

Website

http://www.caflc.co

China Health Technology Group Holding Co Ltd Formerly China Bozza Development Holdings Ltd is an investment holding company. It is engaged in the business of management of new agriculture and forestry resources in the People's Republic of China. The company has two reportable segments including the Forestry business; Horny Goat Weed Business; and Ginseng Business. The forestry management business includes plantation, logging, and sale of timber-related products and the Ginseng Business includes ginseng plantation and trading of related products. The company generates a majority of its revenue from the Forestry business segment. Geographically company generates its key revenue from the PRC.

Executives

Huang Hou	2201 Interest of corporation controlled by you
Huang Hou	2101 Beneficial owner
Able Planet International Limited
China Bozza Scheme Limited
Arab Osman Mohammed
Lai Wing Lun
Wang Yue	2101 Beneficial owner
Long Yijia	2202 Interest of your spouse

China Health Technology Group Holding Co Headlines

No Headlines